Option Care Health, Inc. (OPCH)
USD 32.18
(0.22%)
USD 32.18
(0.22%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 274 Million USD | 22.17% |
| 2022 | 224.28 Million USD | 22.49% |
| 2021 | 183.09 Million USD | 15.44% |
| 2020 | 158.6 Million USD | 36.87% |
| 2019 | 115.87 Million USD | 334.17% |
| 2018 | 26.68 Million USD | -28.39% |
| 2017 | 37.27 Million USD | 3.06% |
| 2016 | 36.16 Million USD | -15.86% |
| 2015 | 42.98 Million USD | 15.5% |
| 2014 | 37.21 Million USD | 8.37% |
| 2013 | 34.34 Million USD | 0.9% |
| 2012 | 34.03 Million USD | -40.02% |
| 2011 | 56.74 Million USD | -14.68% |
| 2010 | 66.5 Million USD | 29.76% |
| 2009 | 51.25 Million USD | 13.33% |
| 2008 | 45.22 Million USD | 34.61% |
| 2007 | 33.59 Million USD | 0.38% |
| 2006 | 33.47 Million USD | 29.37% |
| 2005 | 25.87 Million USD | 117.47% |
| 2004 | 11.89 Million USD | 39.1% |
| 2003 | 8.55 Million USD | -8.23% |
| 2002 | 9.32 Million USD | 150.13% |
| 2001 | 3.72 Million USD | 42.65% |
| 2000 | 2.61 Million USD | 236.16% |
| 1999 | 777 Thousand USD | -35.25% |
| 1998 | 1.2 Million USD | 0.0% |
| 1997 | - USD | 0.0% |
| 1996 | - USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 281.42 Million USD | 16.31% |
| 2024 Q3 | 310.59 Million USD | 10.37% |
| 2024 Q1 | 241.94 Million USD | -11.7% |
| 2023 FY | 274 Million USD | 22.17% |
| 2023 Q1 | 249.64 Million USD | 11.31% |
| 2023 Q4 | 274 Million USD | 9.01% |
| 2023 Q3 | 251.36 Million USD | -4.4% |
| 2023 Q2 | 262.92 Million USD | 5.32% |
| 2022 Q1 | 217.18 Million USD | 18.62% |
| 2022 FY | 224.28 Million USD | 22.49% |
| 2022 Q2 | 231.76 Million USD | 6.71% |
| 2022 Q4 | 224.28 Million USD | -4.97% |
| 2022 Q3 | 236.02 Million USD | 1.84% |
| 2021 Q3 | 189.83 Million USD | 9.19% |
| 2021 Q1 | 173.62 Million USD | 9.47% |
| 2021 FY | 183.09 Million USD | 15.44% |
| 2021 Q4 | 183.09 Million USD | -3.55% |
| 2021 Q2 | 173.85 Million USD | 0.13% |
| 2020 Q2 | 149.11 Million USD | 7.18% |
| 2020 Q1 | 139.12 Million USD | 20.07% |
| 2020 Q3 | 155.47 Million USD | 4.27% |
| 2020 FY | 158.6 Million USD | 36.87% |
| 2020 Q4 | 158.6 Million USD | 2.01% |
| 2019 Q1 | 27.47 Million USD | 2.93% |
| 2019 FY | 115.87 Million USD | 334.17% |
| 2019 Q3 | 109.23 Million USD | 292.92% |
| 2019 Q2 | 27.8 Million USD | 1.2% |
| 2019 Q4 | 115.87 Million USD | 6.08% |
| 2018 FY | 26.68 Million USD | -28.39% |
| 2018 Q4 | 26.68 Million USD | 15.51% |
| 2018 Q1 | 41.54 Million USD | 11.48% |
| 2018 Q2 | 25.28 Million USD | -39.14% |
| 2018 Q3 | 23.1 Million USD | -8.63% |
| 2017 Q2 | 28.82 Million USD | -5.65% |
| 2017 Q4 | 37.27 Million USD | 34.19% |
| 2017 Q1 | 30.54 Million USD | -15.53% |
| 2017 FY | 37.27 Million USD | 3.06% |
| 2017 Q3 | 27.77 Million USD | -3.63% |
| 2016 FY | 36.16 Million USD | -15.86% |
| 2016 Q1 | 29.11 Million USD | -32.26% |
| 2016 Q4 | 36.16 Million USD | 8.34% |
| 2016 Q3 | 33.38 Million USD | 2.88% |
| 2016 Q2 | 32.44 Million USD | 11.44% |
| 2015 Q2 | 42.36 Million USD | 1.15% |
| 2015 Q1 | 41.88 Million USD | 12.54% |
| 2015 FY | 42.98 Million USD | 15.5% |
| 2015 Q4 | 42.98 Million USD | 59.87% |
| 2015 Q3 | 26.88 Million USD | -36.54% |
| 2014 Q3 | 33.77 Million USD | -2.03% |
| 2014 Q1 | 34.75 Million USD | 1.2% |
| 2014 Q4 | 37.21 Million USD | 10.18% |
| 2014 FY | 37.21 Million USD | 8.37% |
| 2014 Q2 | 34.47 Million USD | -0.79% |
| 2013 Q2 | 25.92 Million USD | 13.59% |
| 2013 Q3 | 30.32 Million USD | 16.99% |
| 2013 FY | 34.34 Million USD | 0.9% |
| 2013 Q1 | 22.81 Million USD | -32.95% |
| 2013 Q4 | 34.34 Million USD | 13.24% |
| 2012 Q4 | 34.03 Million USD | -7.0% |
| 2012 Q1 | 13.78 Million USD | -75.71% |
| 2012 FY | 34.03 Million USD | -40.02% |
| 2012 Q2 | 21.24 Million USD | 54.12% |
| 2012 Q3 | 36.59 Million USD | 72.28% |
| 2011 FY | 56.74 Million USD | -14.68% |
| 2011 Q4 | 56.74 Million USD | 49.42% |
| 2011 Q3 | 37.97 Million USD | -6.23% |
| 2011 Q2 | 40.5 Million USD | -5.55% |
| 2011 Q1 | 42.88 Million USD | -35.52% |
| 2010 Q2 | 54.08 Million USD | -10.46% |
| 2010 Q4 | 66.5 Million USD | 0.28% |
| 2010 Q3 | 66.32 Million USD | 22.62% |
| 2010 FY | 66.5 Million USD | 29.76% |
| 2010 Q1 | 60.4 Million USD | 17.85% |
| 2009 Q2 | 48.5 Million USD | 24.24% |
| 2009 Q1 | 39.04 Million USD | -13.68% |
| 2009 Q4 | 51.25 Million USD | 7.16% |
| 2009 FY | 51.25 Million USD | 13.33% |
| 2009 Q3 | 47.83 Million USD | -1.38% |
| 2008 Q2 | 36.3 Million USD | 5.18% |
| 2008 Q3 | 36.15 Million USD | -0.4% |
| 2008 Q4 | 45.22 Million USD | 25.09% |
| 2008 FY | 45.22 Million USD | 34.61% |
| 2008 Q1 | 34.51 Million USD | 2.73% |
| 2007 Q4 | 33.59 Million USD | 0.64% |
| 2007 Q3 | 33.38 Million USD | -4.07% |
| 2007 Q2 | 34.8 Million USD | -4.96% |
| 2007 Q1 | 36.61 Million USD | 9.4% |
| 2007 FY | 33.59 Million USD | 0.38% |
| 2006 FY | 33.47 Million USD | 29.37% |
| 2006 Q2 | 29.66 Million USD | 0.87% |
| 2006 Q3 | 28.81 Million USD | -2.85% |
| 2006 Q1 | 29.4 Million USD | 13.65% |
| 2006 Q4 | 33.47 Million USD | 16.16% |
| 2005 Q3 | 23.72 Million USD | 1.01% |
| 2005 Q4 | 25.87 Million USD | 9.07% |
| 2005 Q2 | 23.48 Million USD | 2.57% |
| 2005 Q1 | 22.89 Million USD | 92.44% |
| 2005 FY | 25.87 Million USD | 117.47% |
| 2004 FY | 11.89 Million USD | 39.1% |
| 2004 Q3 | 10.05 Million USD | 31.25% |
| 2004 Q2 | 7.65 Million USD | 3.92% |
| 2004 Q1 | 7.36 Million USD | -13.85% |
| 2004 Q4 | 11.89 Million USD | 18.38% |
| 2003 FY | 8.55 Million USD | -8.23% |
| 2003 Q4 | 8.55 Million USD | 33.52% |
| 2003 Q1 | 5.94 Million USD | -36.19% |
| 2003 Q2 | 6.64 Million USD | 11.8% |
| 2003 Q3 | 6.4 Million USD | -3.65% |
| 2002 FY | 9.32 Million USD | 150.13% |
| 2002 Q3 | 9.54 Million USD | -18.87% |
| 2002 Q2 | 11.76 Million USD | 17.56% |
| 2002 Q4 | 9.32 Million USD | -2.38% |
| 2002 Q1 | 10 Million USD | 168.63% |
| 2001 Q4 | 3.72 Million USD | -8.05% |
| 2001 Q2 | 2.39 Million USD | -38.72% |
| 2001 Q1 | 3.9 Million USD | 49.62% |
| 2001 FY | 3.72 Million USD | 42.65% |
| 2001 Q3 | 4.05 Million USD | 69.19% |
| 2000 Q4 | 2.61 Million USD | 47.07% |
| 2000 Q1 | 1.14 Million USD | 47.62% |
| 2000 Q2 | 1.35 Million USD | 18.31% |
| 2000 Q3 | 1.77 Million USD | 30.88% |
| 2000 FY | 2.61 Million USD | 236.16% |
| 1999 FY | 777 Thousand USD | -35.25% |
| 1999 Q2 | 900 Thousand USD | -10.0% |
| 1999 Q3 | 1 Million USD | 11.11% |
| 1999 Q4 | 777 Thousand USD | -22.3% |
| 1999 Q1 | 1 Million USD | -16.67% |
| 1998 Q4 | 1.2 Million USD | 33.33% |
| 1998 Q3 | 900 Thousand USD | 0.0% |
| 1998 FY | 1.2 Million USD | 0.0% |
| 1998 Q1 | - USD | 0.0% |
| 1998 Q2 | - USD | 0.0% |
| 1997 Q1 | - USD | 0.0% |
| 1997 Q3 | - USD | 0.0% |
| 1997 Q4 | - USD | 0.0% |
| 1997 FY | - USD | 0.0% |
| 1997 Q2 | - USD | 0.0% |
| 1996 Q3 | - USD | 0.0% |
| 1996 FY | - USD | 0.0% |
| 1996 Q4 | - USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 5.3 Million USD | -5069.887% |
| Addus HomeCare Corporation | - USD | -Infinity% |
| AirSculpt Technologies, Inc. | - USD | -Infinity% |
| Amedisys, Inc. | - USD | -Infinity% |
| American Oncology Network, Inc. | 44.56 Million USD | -514.786% |
| Astrana Health, Inc. | - USD | -Infinity% |
| Aveanna Healthcare Holdings Inc. | - USD | -Infinity% |
| IMAC Holdings, Inc. | - USD | -Infinity% |
| biote Corp. | 20.94 Million USD | -1208.207% |
| Cryo-Cell International, Inc. | 768.87 Thousand USD | -35536.909% |
| Cross Country Healthcare, Inc. | - USD | -Infinity% |
| COMPASS Pathways plc | 1.00 USD | -27400399900.0% |
| DocGo Inc. | 1.00 USD | -27400399900.0% |
| The Ensign Group, Inc. | - USD | -Infinity% |
| Healthcare Services Group, Inc. | 18.47 Million USD | -1382.786% |
| InnovAge Holding Corp. | -3.32 Million USD | 8343.201% |
| Assure Holdings Corp. | 1.00 USD | -27400399900.0% |
| The Joint Corp. | - USD | -Infinity% |
| LifeStance Health Group, Inc. | 1.00 USD | -27400399900.0% |
| Mobile-health Network Solutions Class A Ordinary Shares | 163.99 Thousand USD | -166982.741% |
| ModivCare Inc. | - USD | -Infinity% |
| NewGenIvf Group Limited | 126.26 Thousand USD | -216908.807% |
| Novo Integrated Sciences, Inc. | 1.1 Million USD | -24652.322% |
| P3 Health Partners Inc. | - USD | -Infinity% |
| P3 Health Partners Inc. | - USD | -Infinity% |
| The Pennant Group, Inc. | - USD | -Infinity% |
| Surgery Partners, Inc. | 75.2 Million USD | -264.367% |
| Syra Health Corp. Class A Common Stock | 1.00 USD | -27400399900.0% |
| Talkspace, Inc. | - USD | -Infinity% |
| Talkspace, Inc. | - USD | -Infinity% |
| The Oncology Institute, Inc. | 13.67 Million USD | -1903.246% |
| The Oncology Institute, Inc. | 13.67 Million USD | -1903.246% |